Results
|
|
2221.
|
Interferon and doxorubicin in renal cell carcinoma. [electronic resource] by
- Muss, H B
- Welander, C
- Caponera, M
- Reavis, K
- Cruz, J M
- Cooper, M R
- Jackson, D V
- Richards, F
- Stuart, J J
- Spurr, C L
Producer: 19850912
In:
Cancer treatment reports vol. 69
Availability: No items available.
|
|
|
2222.
|
|
|
|
2223.
|
|
|
|
2224.
|
|
|
|
2225.
|
|
|
|
2226.
|
|
|
|
2227.
|
Classification of primary immunodeficiencies. [electronic resource] by
- Cooper, M D
- Faulk, W P
- Fudenberg, H H
- Good, R A
- Hitzig, W
- Kunkel, H
- Rosen, F S
- Seligmann, M
- Soothill, J
- Wedgwood, R J
Producer: 19730518
In:
The New England journal of medicine vol. 288
Availability: No items available.
|
|
|
2228.
|
|
|
|
2229.
|
Dose-response trial of megestrol acetate in advanced breast cancer: cancer and leukemia group B phase III study 8741. [electronic resource] by
- Abrams, J
- Aisner, J
- Cirrincione, C
- Berry, D A
- Muss, H B
- Cooper, M R
- Henderson, I C
- Panasci, L
- Kirshner, J
- Ellerton, J
- Norton, L
Producer: 19990903
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 17
Availability: No items available.
|
|
|
2230.
|
Teaching the microscopic examination of urine sediment to second year medical students using the Urinalysis-Tutor computer program. [electronic resource] by
- Phillips, C
- Henderson, P J
- Mandel, L
- Kim, S
- Schaad, D
- Cooper, M
- Bien, C
- Orkand, A
- Wener, M H
- Fine, J S
- Astion, M L
Producer: 19980820
In:
Clinical chemistry vol. 44
Availability: No items available.
|
|
|
2231.
|
Inhibition of IgE-mediated mast cell activation by the paired Ig-like receptor PIR-B. [electronic resource] by
- Uehara, T
- Bléry, M
- Kang, D W
- Chen, C C
- Ho, L H
- Gartland, G L
- Liu, F T
- Vivier, E
- Cooper, M D
- Kubagawa, H
Producer: 20011204
In:
The Journal of clinical investigation vol. 108
Availability: No items available.
|
|
|
2232.
|
|
|
|
2233.
|
Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study. [electronic resource] by
- Boner, G
- Cooper, M E
- McCarroll, K
- Brenner, B M
- de Zeeuw, D
- Kowey, P R
- Shahinfar, S
- Dickson, T
- Crow, R S
- Parving, H-H
Producer: 20051220
In:
Diabetologia vol. 48
Availability: No items available.
|
|
|
2234.
|
Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myeloma. [electronic resource] by
- Siu, K T
- Ramachandran, J
- Yee, A J
- Eda, H
- Santo, L
- Panaroni, C
- Mertz, J A
- Sims Iii, R J
- Cooper, M R
- Raje, N
Producer: 20171009
In:
Leukemia vol. 31
Availability: No items available.
|
|
|
2235.
|
Phase I trials of high-dose cytosine arabinoside (HDara-C) and HDara-C plus cisplatin in patients with advanced malignancies. [electronic resource] by
- Muss, H B
- Capizzi, R L
- Atkins, J N
- Powell, B L
- Cooper, M R
- Ferree, D
- McMahan, R A
- Jobson, V
- Craig, J
- Homesley, H D
Producer: 19850807
In:
Seminars in oncology vol. 12
Availability: No items available.
|
|
|
2236.
|
Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells. [electronic resource] by
- Fehniger, T A
- Suzuki, K
- Ponnappan, A
- VanDeusen, J B
- Cooper, M A
- Florea, S M
- Freud, A G
- Robinson, M L
- Durbin, J
- Caligiuri, M A
Producer: 20010517
In:
The Journal of experimental medicine vol. 193
Availability: No items available.
|
|
|
2237.
|
Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. [electronic resource] by
- Fehniger, T A
- Shah, M H
- Turner, M J
- VanDeusen, J B
- Whitman, S P
- Cooper, M A
- Suzuki, K
- Wechser, M
- Goodsaid, F
- Caligiuri, M A
Producer: 19990506
In:
Journal of immunology (Baltimore, Md. : 1950) vol. 162
Availability: No items available.
|
|
|
2238.
|
The Tcl1 oncogene defines secondary hair germ cells differentiation at catagen-telogen transition and affects stem-cell marker CD34 expression. [electronic resource] by
- Ragone, G
- Bresin, A
- Piermarini, F
- Lazzeri, C
- Picchio, M C
- Remotti, D
- Kang, S-M
- Cooper, M D
- Croce, C M
- Narducci, M G
- Russo, G
Producer: 20090325
In:
Oncogene vol. 28
Availability: No items available.
|
|
|
2239.
|
Comparison of the combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and vincristine with two dose schedules of 5-(3,3-dimethyl-1-triazino) imidazole 4-carboxamide (DTIC) in the treatment of disseminated malignant melanoma. [electronic resource] by
- Moon, J H
- Gailani, S
- Cooper, M R
- Hayes, D M
- Rege, V B
- Blom, J
- Falkson, G
- Maurice, P
- Brunner, K
- Glidewell, O
- Holland, J F
Producer: 19750509
In:
Cancer vol. 35
Availability: No items available.
|
|
|
2240.
|
Bone marrow evaluation in small cell lung cancer. [electronic resource] by
- Muss, H B
- Jackson, D V
- Richards, F
- White, D R
- Cooper, M R
- Stuart, J J
- Spurr, C L
- Lawhon, K
- Watson, N E
- Shore, A
Producer: 19840323
In:
American journal of clinical oncology vol. 7
Availability: No items available.
|